Oasmia Pharmaceutical AB publ announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was SEK 37,000 compared to SEK 2.140 million a year ago. Operating loss was SEK 40.842 million compared to operating Income of SEK 128.607 million a year ago. Net loss was SEK 41.209 million compared to net income of SEK 124.706 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to basic earnings per share from continuing operations of SEK 0.28 a year ago.